CA2079325A1 - Supplement nutritionnel contenant de la vitamine e - Google Patents

Supplement nutritionnel contenant de la vitamine e

Info

Publication number
CA2079325A1
CA2079325A1 CA2079325A CA2079325A CA2079325A1 CA 2079325 A1 CA2079325 A1 CA 2079325A1 CA 2079325 A CA2079325 A CA 2079325A CA 2079325 A CA2079325 A CA 2079325A CA 2079325 A1 CA2079325 A1 CA 2079325A1
Authority
CA
Canada
Prior art keywords
nutritional supplement
containing vitamin
supplement containing
vitamin
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2079325A
Other languages
English (en)
Other versions
CA2079325C (fr
Inventor
Carol Juilliard Greene
Stephen Hong-Wei Wu
Andreas Michael Papas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eastman Chemical Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2079325A1 publication Critical patent/CA2079325A1/fr
Application granted granted Critical
Publication of CA2079325C publication Critical patent/CA2079325C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CA002079325A 1991-02-11 1992-02-10 Supplement nutritionnel contenant de la vitamine e Expired - Fee Related CA2079325C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/653,832 US5179122A (en) 1991-02-11 1991-02-11 Nutritional supplement containing vitamin e
US653,832 1991-02-11

Publications (2)

Publication Number Publication Date
CA2079325A1 true CA2079325A1 (fr) 1992-08-12
CA2079325C CA2079325C (fr) 1995-10-31

Family

ID=24622458

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002079325A Expired - Fee Related CA2079325C (fr) 1991-02-11 1992-02-10 Supplement nutritionnel contenant de la vitamine e

Country Status (5)

Country Link
US (1) US5179122A (fr)
EP (1) EP0524308A1 (fr)
JP (1) JPH05506458A (fr)
CA (1) CA2079325C (fr)
WO (1) WO1992013531A1 (fr)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567592A (en) * 1994-02-02 1996-10-22 Regents Of The University Of California Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
CN1129400A (zh) * 1994-05-06 1996-08-21 阿尔康实验室公司 维生素e生育酚衍生物在眼科组合物中的应用
GB9409778D0 (en) * 1994-05-16 1994-07-06 Dumex Ltd As Compositions
CA2159419C (fr) * 1994-10-17 2006-07-04 Pieter De Haan Composition pharmaceutique solide renfermant un excipient pouvant fixer l'eau
US5665386A (en) * 1995-06-07 1997-09-09 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
US5716928A (en) * 1995-06-07 1998-02-10 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
CA2224227A1 (fr) * 1995-06-07 1996-12-19 Avmax, Inc. Utilisation d'huiles essentielles pour accroitre la biodisponibilite des composes pharmaceutiques oraux
US6730679B1 (en) 1996-03-22 2004-05-04 Smithkline Beecham Corporation Pharmaceutical formulations
IL117773A (en) * 1996-04-02 2000-10-31 Pharmos Ltd Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability
US5696101A (en) * 1996-04-16 1997-12-09 Eastman Chemical Company Oxidized cellulose and vitamin E blend for topical hemostatic applications
US5891469A (en) * 1997-04-02 1999-04-06 Pharmos Corporation Solid Coprecipitates for enhanced bioavailability of lipophilic substances
JP2001523221A (ja) * 1996-09-01 2001-11-20 ファーモス コーポレイション 親油性物質の促進された生物学的利用能のための固形共沈物
US6949264B1 (en) 1996-11-27 2005-09-27 Wm. Wrigley Jr. Company Nutraceuticals or nutritional supplements and method of making
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
KR100335719B1 (ko) * 1997-04-09 2002-06-20 서경배 아연피리치온현탁액의제조방법및이를이용한모발조성물
US7030155B2 (en) * 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6303167B1 (en) * 1998-11-09 2001-10-16 Archer-Daniels-Midland Company Method of producing vitamin powders
US6531114B1 (en) 1999-04-06 2003-03-11 Wm. Wrigley Jr. Company Sildenafil citrate chewing gum formulations and methods of using the same
US7163705B2 (en) * 1998-12-15 2007-01-16 Wm. Wrigley Jr. Company Coated chewing gum product and method of making
US6627234B1 (en) 1998-12-15 2003-09-30 Wm. Wrigley Jr. Company Method of producing active agent coated chewing gum products
US6586023B1 (en) 1998-12-15 2003-07-01 Wm. Wrigley Jr. Company Process for controlling release of active agents from a chewing gum coating and product thereof
US20080070981A1 (en) * 2000-02-23 2008-03-20 Henryk Borowy-Borowski Water-soluble compositions of bioactive lipophilic compounds
US6632443B2 (en) * 2000-02-23 2003-10-14 National Research Council Of Canada Water-soluble compositions of bioactive lipophilic compounds
US6045826A (en) * 1999-04-02 2000-04-04 National Research Council Of Canada Water-soluble compositions of bioactive lipophilic compounds
US7935362B2 (en) * 1999-04-06 2011-05-03 Wm. Wrigley Jr. Company Over-coated product including consumable center and medicament
US20020159956A1 (en) * 1999-04-06 2002-10-31 Ream Ronald L. Over-coated chewing gum formulations
US6322806B1 (en) 1999-04-06 2001-11-27 Wm. Wrigley Jr. Company Over-coated chewing gum formulations including tableted center
US6773716B2 (en) 1999-04-06 2004-08-10 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6426090B1 (en) * 1999-04-06 2002-07-30 Wm. Wrigley Jr. Company Over-coated product including tableted center and medicament
US6355265B1 (en) 1999-04-06 2002-03-12 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6569472B1 (en) 2000-09-01 2003-05-27 Wm. Wrigley Jr. Company Coated chewing gum products containing antacid and method of making
US6663849B1 (en) 2000-09-01 2003-12-16 Wm. Wrigley Jr. Company Antacid chewing gum products coated with high viscosity materials
US6645535B2 (en) 1999-09-02 2003-11-11 Wm. Wrigley Jr. Company Method of making coated chewing gum products containing various antacids
US6541048B2 (en) 1999-09-02 2003-04-01 Wm. Wrigley Jr. Company Coated chewing gum products containing an acid blocker and process of preparing
US9253991B2 (en) 1999-09-20 2016-02-09 Jack Barreca Chewing gum with B vitamins
US9387168B2 (en) 1999-09-20 2016-07-12 Jack Barreca Chewing gum with tomatidine
WO2001021147A1 (fr) * 1999-09-20 2001-03-29 Mastercare Gomme a macher et sucette de regime et de controle ponderal
US6716451B1 (en) * 1999-11-30 2004-04-06 Soft Gel Technologies, Inc. Formulation and delivery method to enhance antioxidant potency of vitamin E
US6572900B1 (en) 2000-06-09 2003-06-03 Wm. Wrigley, Jr. Company Method for making coated chewing gum products including a high-intensity sweetener
US7115288B2 (en) * 2000-06-09 2006-10-03 Wm. Wrigley Jr. Company Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener
US6444241B1 (en) 2000-08-30 2002-09-03 Wm. Wrigley Jr. Company Caffeine coated chewing gum product and process of making
WO2002045737A2 (fr) * 2000-12-07 2002-06-13 Board Of Regents, The University Of Texas System Procedes de traitement mettant en application mda-7 humain
US6579545B2 (en) 2000-12-22 2003-06-17 Wm. Wrigley Jr. Company Coated chewing gum products containing an antigas agent
WO2002057283A1 (fr) * 2001-01-19 2002-07-25 Baylor College Of Medecine Methodes et compositions utiles dans le diagnostic et le traitement du cancer du sein
US7090862B2 (en) 2001-03-30 2006-08-15 Abbott Laboratories Method of improving the antioxidant status of an infant
US7923469B2 (en) 2001-04-30 2011-04-12 Allergen, Inc. Compositions including vitamin-based surfactants and methods for using same
AU2003228267A1 (en) * 2002-03-05 2003-09-22 Board Of Regents, The University Of Texas System Methods of enhancing immune induction involving mda-7
US8697115B2 (en) * 2002-03-29 2014-04-15 Abbott Laboratories Method of improving antioxidant status of an infant
US7329688B2 (en) * 2002-12-17 2008-02-12 Soft Gel Technologies, Inc. Natural vitamin E compositions with superior antioxidant potency
WO2004073687A1 (fr) * 2003-02-19 2004-09-02 H. Lundbeck A/S Procede de preparation d'un agglomere par agglomeration a chaud
DE10311585A1 (de) 2003-03-14 2004-09-23 Basf Ag Wirkstoffhaltige Adsorbate
US20050074444A1 (en) * 2003-10-01 2005-04-07 Papas Andreas M. Coenzyme Q10 treatment for cystic fibrosis
WO2005042510A1 (fr) * 2003-10-27 2005-05-12 Eastman Chemical Company Articles en succinate de glycol de polyethylene de tocopheryle (tpgs) et procede de preparation d'articles tpgs
WO2005082396A2 (fr) * 2003-12-01 2005-09-09 Introgen Therapeutics, Inc. Utilisation de mda-7 pour inhiber des organismes infectieux pathogenes
US20070281041A1 (en) * 2004-03-02 2007-12-06 Introgen Therapeutics, Inc. Compositions and Methods Involving MDA-7 for the Treatment of Cancer
US20060088591A1 (en) * 2004-10-22 2006-04-27 Jinghua Yuan Tablets from a poorly compressible substance
AU2006211960A1 (en) * 2005-02-08 2006-08-17 Board Of Regents, The University Of Texas System Compositions and methods involving MDA-7 for the treatment of cancer
US20060182722A1 (en) * 2005-02-11 2006-08-17 Hering Bernhard J Methods and materials for isolating isogenic islet cells
DE102005013768A1 (de) * 2005-03-22 2006-09-28 Henkel Kgaa Schäumbare kosmetische Zusammensetzungen
US8252326B2 (en) * 2005-06-01 2012-08-28 Catalent Australia Pty Ltd. Self-microemulsifying dosage forms of low solubility active ingredients such as co-enzyme Q10
CN101232871A (zh) * 2005-08-03 2008-07-30 伊士曼化工公司 生育酚聚乙二醇琥珀酸酯粉末及其制备方法
WO2007092944A2 (fr) * 2006-02-08 2007-08-16 Introgen Therapeutics, Inc. Compositions et procedes impliquant une therapie de gene et une modulation de proteasome
BRPI0909185A2 (pt) 2008-03-20 2015-08-25 Virun Inc Derivado de vitamina e e seus usos
PL2268160T3 (pl) * 2008-03-20 2013-05-31 Virun Inc Emulsje zawierające pochodną PEG tokoferolu
US10210216B2 (en) * 2009-12-18 2019-02-19 Sybase, Inc. Dynamic attributes for mobile business objects
CA2792330C (fr) 2010-03-23 2017-01-03 Virun, Inc Nanoemulsion comportant un derive peg de vitamine e et un sucrose ester d'acide gras
WO2011162802A1 (fr) 2010-06-21 2011-12-29 Virun, Inc. Compositions contenant des composés non polaires
CN103384478B (zh) 2010-12-29 2016-11-23 雅培制药有限公司 降低婴儿、幼儿或儿童的坏死性小肠结肠炎、腹痛和短肠综合征的发病率的方法
US10874122B2 (en) 2012-02-10 2020-12-29 Virun, Inc. Beverage compositions containing non-polar compounds
US9744240B2 (en) 2012-09-27 2017-08-29 Basf Se Storage-stable dust-free homogeneous particulate formulation comprising at least one water-soluble vitamin E-derivative and at least one hydrophilic polymer
US9789063B2 (en) 2012-09-27 2017-10-17 Basf Se Storage-stable dust-free homogeneous particulate formulation
CN104684545B (zh) 2012-09-27 2018-04-03 巴斯夫欧洲公司 包含至少一种水溶性维生素e衍生物和至少一种亲水聚合物的储存稳定的无粉尘均质颗粒状配制剂
EP2900219B1 (fr) 2012-09-27 2016-07-06 Basf Se Formulation particulaire homogène sans poussière stable en stockage comprenant au moins un dérivé de vitamine e hydrosoluble et au moins un polymère hydrophile
US9351517B2 (en) 2013-03-15 2016-05-31 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and compositions containing same
US9693574B2 (en) 2013-08-08 2017-07-04 Virun, Inc. Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch
US9861611B2 (en) 2014-09-18 2018-01-09 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
US10016363B2 (en) 2014-09-18 2018-07-10 Virun, Inc. Pre-spray emulsions and powders containing non-polar compounds
WO2018081048A1 (fr) * 2016-10-24 2018-05-03 Callion Pharma Composition multivitaminique enrichie en antioxydants, et méthodes d'utilisation
CN106690277B (zh) * 2016-12-29 2020-05-22 浙江新和成股份有限公司 一种固载化脂溶性营养素制剂及其制备方法和应用
CN114886122B (zh) * 2022-05-12 2023-10-10 浙江花园营养科技有限公司 一种改善性能的维生素e粉的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE564287A (fr) * 1957-01-28
US3253992A (en) * 1962-09-27 1966-05-31 Eastman Kodak Co Water dispersible, anhydrous, water insoluble vitamin preparation and aqueous dispersions thereof
US4201235A (en) * 1978-01-03 1980-05-06 Mare Corporation Amino acid-vitamin formulations for skin, hair and scalp conditioners
US4231802A (en) * 1978-07-10 1980-11-04 Fmc Corporation Method of mixing difficulty dispersible material, e.g., fat or wax, in a gum-microcrystalline cellulose matrix, and powder product
DE3224619A1 (de) * 1981-07-14 1983-05-19 Freund Industrial Co., Ltd., Tokyo Orale pharmazeutische zusammensetzung
US4551332A (en) * 1981-08-05 1985-11-05 Theodore Stillman Vitamin E compositions and methods
CA1282326C (fr) * 1984-12-14 1991-04-02 Paul J. Jarosz Compose pharmaceutique contenant de la vitamine a 13-cis acide comme ingredient actif
WO1989003689A1 (fr) * 1987-10-19 1989-05-05 The Liposome Company, Inc. Systemes pharmaceutiques a base de tocopherol
US4954332A (en) * 1987-10-22 1990-09-04 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent

Also Published As

Publication number Publication date
WO1992013531A1 (fr) 1992-08-20
EP0524308A1 (fr) 1993-01-27
JPH05506458A (ja) 1993-09-22
CA2079325C (fr) 1995-10-31
US5179122A (en) 1993-01-12

Similar Documents

Publication Publication Date Title
CA2079325A1 (fr) Supplement nutritionnel contenant de la vitamine e
CA2142126A1 (fr) Poudre a inhaler, renfermant un agent antistatique
CA2092287A1 (fr) Verapamil en microcapsule
CA2163003A1 (fr) Agent de solubilisation et preparation a usage externe a base de cet agent
AU4742193A (en) Cyclohex(en)ylcarboxamides, the preparation thereof, and compositions containing them for controlling fungal pests
EP0610445A4 (fr) Compositions comprenant une proteine a action bactericide/accroissant la permeabilite et un excipient lipidique, procedes pour leur production et utilisations.
GB2216462B (en) Oxygen-scavenging packaging material.
GR3024643T3 (en) Package for pesticides.
AU2926789A (en) Semiconductor package
AU1721392A (en) Resealable packaging material
AU2447288A (en) Drug carriers
PH24442A (en) Vitamin d. compounds
AU7655691A (en) Grain supplying vessel, grain containing body, and grain assemblage
AU8790891A (en) Aluminum alloy powders for coating materials, and coating materials containing the alloy powders
USD277554S (en) Bottle carrier
AU1143892A (en) (4.3.3.0)propellane-8,11-diamine compounds
AU7821491A (en) Carrier for containers
AU2710892A (en) Cytotoxic bicyclo (7.3.1) tridec-4-ene-2,6-diyne compounds and process for the preparation thereof
AU6292390A (en) Resealable package
AU7396291A (en) Cup carrier
AU4028793A (en) Packages
AU1192592A (en) Carrier ring for semiconductor packages
USD279864S (en) Vitamin pill dispenser
AU2368797A (en) Bottle carrier
CA2160483A1 (fr) Lubrifiant renfermant un anti-oxydant

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed